Skip to main content

Angina Pectoris Prophylaxis News

Radial Access for Percutaneous Coronary Intervention Now Dominant Method

THURSDAY, May 16, 2024 – Use of radial access for percutaneous coronary intervention (PCI) increased 2.8-fold in the United States between 2013 and 2022, according to a study presented at the annual...

AHA: Percutaneous Coronary Intervention Significantly Cuts Angina Symptoms

FRIDAY, Nov. 17, 2023 – Percutaneous coronary intervention (PCI) improves symptoms versus placebo among patients with stable angina and taking no chest pain medication, according to a study...

Coronary CTA-Derived Fractional Flow Reserve Can ID Three-Year Outcomes in Angina

TUESDAY, Sept. 12, 2023 – For patients with stable angina pectoris, a coronary computed tomography angiography (CTA)-derived fractional flow reserve (FFR) can identify the three-year risk for...

Espero Pharmaceuticals Receives FDA Approval for GoNitro (nitroglycerin) Sublingual Powder

JACKSONVILLE, Fla. (June 14, 2016) – Espero Pharmaceuticals, Inc., a privately held specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved G...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Angina

Related drug support groups

metoprolol, aspirin, atenolol, Metoprolol Succinate ER, diltiazem, Metoprolol Tartrate, bisoprolol, Arthritis Pain, nifedipine, nitroglycerin